Indoco Remedies Limited (INDOCO.BO)
INR 337.6
(-0.35%)
INR 337.6
(-0.35%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.22 Billion | 1.78 Billion | 1.73 Billion | 822.22 Million | 1.22 Billion | 1.32 Billion |
| Net Income | 984.7 Million | 1.92 Billion | 2.36 Billion | 1.31 Billion | 285.72 Million | -93.12 Million |
| Depreciation & Amortization | 918.7 Million | 706.1 Million | 789.6 Million | 731.25 Million | 708.15 Million | 715.68 Million |
| Deferred income taxes | - | -386.7 Million | - | - | - | - |
| Stock-based compensation | 28.8 Million | 6.6 Million | - | - | - | - |
| Change in working capital | -779.2 Million | -732.1 Million | -1.08 Billion | -1.39 Billion | -14.85 Million | 556.18 Million |
| Other non-cash items | 2.54 Billion | 266.4 Million | -329 Million | 169.12 Million | 249.45 Million | 142.39 Million |
| Investing Cash Flow | -4.31 Billion | -2.08 Billion | -1.21 Billion | -666.93 Million | -559.33 Million | -1.03 Billion |
| Investments in PPE | -4.27 Billion | -2.07 Billion | -1.25 Billion | -768.48 Million | -584.64 Million | -969.48 Million |
| Acquisitions | 16.8 Million | 11.59 Million | 9.37 Million | 2.02 Million | 1.01 Million | 39.52 Million |
| Investment purchases | -62.4 Million | -24.4 Million | -15 Thousand | -85.43 Million | - | -1.11 Million |
| Sales/Maturities of investments | - | 4.61 Million | 26.12 Million | 92.48 Million | - | 14.91 Million |
| Other Investing Activities | -64.3 Million | -1.1 Million | 3.61 Million | 92.48 Million | 24.3 Million | -121.41 Million |
| Financing Cash Flow | 3.18 Billion | 228.1 Million | -443.7 Million | -298.73 Million | -639.49 Million | -161.41 Million |
| Debt repayment | -3.42 Billion | -406.2 Million | -979 Million | -508.35 Million | -538.81 Million | -488.68 Million |
| Dividends payments | -207.05 Million | -207.21 Million | -137.93 Million | -27.88 Million | -33.63 Million | -110.93 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.7 Million | - | - | - | - | - |
| Other Financing Activities | 1.02 Billion | 841.5 Million | 673.2 Million | 237.51 Million | -67.04 Million | 438.2 Million |
| Accounts receivables | -637.8 Million | -787.84 Million | -587.75 Million | -402.76 Million | -178.42 Million | 142.62 Million |
| Accounts payables | 301.1 Million | -86.52 Million | 214.29 Million | -507.02 Million | -50.4 Million | 222.75 Million |
| Inventory | -270.8 Million | -154.7 Million | -726.6 Million | -295.34 Million | -248.66 Million | 99.32 Million |
| Other working capital | -171.7 Million | 296.97 Million | 12.06 Million | -192.99 Million | 462.63 Million | 91.47 Million |
| Cash at beginning of period | 133.48 Million | 174.7 Million | 94.2 Million | 237.62 Million | 207.96 Million | 85.81 Million |
| Cash at end of period | 243.3 Million | 109.3 Million | 174.7 Million | 94.17 Million | 237.62 Million | 207.96 Million |
| Capital Expenditure | -4.27 Billion | -2.07 Billion | -1.25 Billion | -768.48 Million | -584.64 Million | -969.48 Million |
| Effect of forex changes on cash | - | 100 Thousand | - | - | - | - |
| Net cash flow / Change in cash | 109.81 Million | -65.4 Million | 80.5 Million | -143.44 Million | 29.65 Million | 122.15 Million |
| Free Cash Flow | -3.04 Billion | -284.3 Million | 485.1 Million | 53.73 Million | 643.83 Million | 351.65 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 26.2 Million | 984.7 Million | 227 Million | 163 Million | 350.8 Million | 243.9 Million |
| Depreciation & Amortization | - | 918.7 Million | - | 243.5 Million | 214.1 Million | 198.8 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 28.8 Million | - | - | - | - |
| Change in working capital | - | -779.2 Million | - | - | - | - |
| Other non-cash items | -26.2 Million | 2.54 Billion | -227 Million | -163 Million | -350.8 Million | -243.9 Million |
| Investing Cash Flow | - | -4.31 Billion | - | - | - | - |
| Investments in PPE | - | -4.27 Billion | - | - | - | - |
| Acquisitions | - | 16.8 Million | - | - | - | - |
| Investment purchases | - | -62.4 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -64.3 Million | - | - | - | - |
| Financing Cash Flow | - | 3.18 Billion | - | - | - | - |
| Debt repayment | - | -3.42 Billion | - | - | - | - |
| Dividends payments | - | -207.05 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 7.7 Million | - | - | - | - |
| Other Financing Activities | - | 1.02 Billion | - | - | - | - |
| Accounts receivables | - | -637.8 Million | - | - | - | - |
| Accounts payables | - | 301.1 Million | - | - | - | - |
| Inventory | - | -270.8 Million | - | - | - | - |
| Other working capital | - | -171.7 Million | - | - | - | - |
| Cash at beginning of period | - | 133.48 Million | - | 651.8 Million | 301 Million | 133.48 Million |
| Cash at end of period | - | 243.3 Million | - | 163 Million | 651.8 Million | 243.9 Million |
| Capital Expenditure | - | -4.27 Billion | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 109.81 Million | - | -488.8 Million | 350.8 Million | 110.41 Million |
| Free Cash Flow | - | -3.04 Billion | - | 163 Million | 350.8 Million | 243.9 Million |
GRSL
0N66
BYGGP
TSCDF
0QW1
0YSU